SEC
filing details

Document Details

Form
Filing Date
May 5, 2023
Document Date
Mar 31, 2023
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Ultragenyx Pharmaceutical Inc.
Issuer
Ultragenyx Pharmaceutical Inc.
Sign up for Email Alerts
Email Alerts Sign-up